New Zealand markets open in 8 hours 24 minutes

Medtronic plc (MDT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
89.89+0.50 (+0.56%)
At close: 04:00PM EDT
89.89 0.00 (0.00%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 115.29B
Enterprise value 135.31B
Trailing P/E 30.27
Forward P/E 16.47
PEG ratio (5-yr expected) 1.66
Price/sales (ttm)3.64
Price/book (mrq)2.40
Enterprise value/revenue 4.15
Enterprise value/EBITDA 16.33

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 310.43%
S&P500 52-week change 320.52%
52-week high 391.49
52-week low 368.84
50-day moving average 382.13
200-day moving average 382.85

Share statistics

Avg vol (3-month) 36.29M
Avg vol (10-day) 36.1M
Shares outstanding 51.28B
Implied shares outstanding 61.28B
Float 81.28B
% held by insiders 10.26%
% held by institutions 185.91%
Shares short (15 Aug 2024) 414.84M
Short ratio (15 Aug 2024) 42.48
Short % of float (15 Aug 2024) 41.16%
Short % of shares outstanding (15 Aug 2024) 41.16%
Shares short (prior month 15 Jul 2024) 413.68M

Dividends & splits

Forward annual dividend rate 42.8
Forward annual dividend yield 43.11%
Trailing annual dividend rate 32.77
Trailing annual dividend yield 33.10%
5-year average dividend yield 42.61
Payout ratio 493.27%
Dividend date 311 Oct 2024
Ex-dividend date 427 Sept 2024
Last split factor 22:1
Last split date 327 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 26 Apr 2024
Most-recent quarter (mrq)26 Jul 2024

Profitability

Profit margin 12.06%
Operating margin (ttm)17.51%

Management effectiveness

Return on assets (ttm)4.41%
Return on equity (ttm)7.95%

Income statement

Revenue (ttm)32.58B
Revenue per share (ttm)24.71
Quarterly revenue growth (yoy)2.80%
Gross profit (ttm)N/A
EBITDA 9.01B
Net income avi to common (ttm)3.93B
Diluted EPS (ttm)2.97
Quarterly earnings growth (yoy)31.70%

Balance sheet

Total cash (mrq)7.84B
Total cash per share (mrq)6.11
Total debt (mrq)27.86B
Total debt/equity (mrq)57.86%
Current ratio (mrq)2.13
Book value per share (mrq)37.39

Cash flow statement

Operating cash flow (ttm)6.9B
Levered free cash flow (ttm)4.9B